Skip to main content
Morphea secondary to interferon beta1b injection: a case and review of the literature
Published Web Location
https://doi.org/10.5070/D3254043579Abstract
Interferon beta (IFNβ) is a drug used successfully in the treatment of multiple sclerosis (MS). Although IFNβ is a safe and well-tolerated drug, dermatological side effects are common. The most common dermatological adverse effect is a local reaction at the injection site. It may also cause inflammatory and immune-mediated dermatological side effects. However, morphea induced by IFNβ1b injection is very rare